184 related articles for article (PubMed ID: 25228114)
1. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
[TBL] [Abstract][Full Text] [Related]
2. The CFC to HFA transition and its impact on pulmonary drug development.
Leach CL
Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
[TBL] [Abstract][Full Text] [Related]
3. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
Murata S; Izumi T; Ito H
Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
[TBL] [Abstract][Full Text] [Related]
4. Plume temperature emitted from metered dose inhalers.
Brambilla G; Church T; Lewis D; Meakin B
Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
[TBL] [Abstract][Full Text] [Related]
5. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
[TBL] [Abstract][Full Text] [Related]
7. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
8. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
9. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
Ganderton D; Lewis D; Davies R; Meakin B; Church T
Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
[TBL] [Abstract][Full Text] [Related]
10. New delivery systems and propellants.
Dolovich M
Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
[TBL] [Abstract][Full Text] [Related]
11. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
Cheng YS; Fu CS; Yazzie D; Zhou Y
J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
[TBL] [Abstract][Full Text] [Related]
12. Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers.
Ganderton D; Lewis D; Davies R; Meakin B; Brambilla G; Church T
Respir Med; 2002 Aug; 96 Suppl D():S3-8. PubMed ID: 12201079
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
14. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
Johal B; Murphy S; Tuohy J; Marshall J
Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
[TBL] [Abstract][Full Text] [Related]
15. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
16. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
17. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
18. Spray pattern analysis for metered dose inhalers: effect of actuator design.
Smyth H; Brace G; Barbour T; Gallion J; Grove J; Hickey AJ
Pharm Res; 2006 Jul; 23(7):1591-6. PubMed ID: 16783475
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
20. Sub-micrometer particle production by pressurized metered dose inhalers.
Crampton M; Kinnersley R; Ayres J
J Aerosol Med; 2004; 17(1):33-42. PubMed ID: 15120011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
